Paliperidone and Metamyelocyte count increased - a phase IV clinical study of FDA data

Summary:

Metamyelocyte count increased is reported as a side effect among people who take Paliperidone (paliperidone), especially for people who are female, 50-59 old, also take Clozaril, and have Schizophrenia.

The phase IV clinical study analyzes which people have Metamyelocyte count increased when taking Paliperidone. It is created by eHealthMe based on reports of 5,118 people who have side effects when taking Paliperidone from the FDA, and is updated regularly.

What is Paliperidone?

Paliperidone has active ingredients of paliperidone. eHealthMe is studying from 5,137 Paliperidone users. Check the latest studies of Paliperidone.

What is Metamyelocyte count increased?

Metamyelocyte count increased (excess precursor in the granulocytic series) is found to be associated with 51 drugs and 84 conditions by eHealthMe. Check the latest studies of Metamyelocyte count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

5,118 people reported to have side effects when taking Paliperidone.
Among them, 20 people (0.39%) have Metamyelocyte count increased.

Could Paliperidone cause Metamyelocyte count increased?

Among these 20 people:

What is the gender of people who have Metamyelocyte count increased when taking Paliperidone? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Metamyelocyte count increased when taking Paliperidone? *

What are other drugs people take besides Paliperidone? *

What are other side effects people have besides Metamyelocyte count increased? *

Myelocyte Count Increased (a young white blood cell found in the bone marrow increased): 20 people, 100.00%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 20 people, 100.00%
Hyperhidrosis (abnormally increased sweating): 16 people, 80.00%
Delusion (a false belief or opinion): 16 people, 80.00%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 16 people, 80.00%
Emotional Distress: 16 people, 80.00%
Eosinophil Count Decreased: 16 people, 80.00%
Feeling Cold: 16 people, 80.00%
Haemoglobin Decreased: 16 people, 80.00%
Monocyte Count Decreased: 16 people, 80.00%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 10 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Paliperidone and have Metamyelocyte count increased?

- Check whether Metamyelocyte count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paliperidone:

Paliperidone (5,137 reports)

Browse all side effects of Paliperidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metamyelocyte count increased:

Metamyelocyte count increased (51 drugs)

Browse all the conditions that are associated with Metamyelocyte count increased:

Metamyelocyte count increased (84 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone (the active ingredients of Paliperidone) and Paliperidone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.